Comparison of the Interactions of Transferrin Receptor and Transferrin Receptor 2 with Transferrin and the Hereditary Hemochromatosis Protein HFE

The transferrin receptor (TfR) interacts with two proteins important for iron metabolism, transferrin (Tf) and HFE, the protein mutated in hereditary hemochromatosis. A second receptor for Tf, TfR2, was recently identified and found to be functional for iron uptake in transfected cells (Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., Said, J. W., and Koeffler, H. P. (2000) J. Biol. Chem. 275, 16618-16625). TfR2 has a pattern of expression and regulation that is distinct from TfR, and mutations in TfR2 have been recognized as the cause of a non-HFE linked form of hemochromatosis (Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., and Gasparini, P. (2000) Nat. Genet. 25, 14-15). To investigate the relationship between TfR, TfR2, Tf, and HFE, we performed a series of binding experiments using soluble forms of these proteins. We find no detectable binding between TfR2 and HFE by co-immunoprecipitation or using a surface plasmon resonance-based assay. The affinity of TfR2 for iron-loaded Tf was determined to be 27 nM, 25-fold lower than the affinity of TfR for Tf. These results imply that HFE regulates Tf-mediated iron uptake only from the classical TfR and that TfR2 does not compete for HFE binding in cells expressing both forms of TfR

Healthfulness of Fast-Food and Full-Service Restaurants in 16 Georgia Counties after Mandatory Menu Labeling

Background: Despite that the effect of menu labeling on consumer choices has been studied, there are gaps in the research on the healthfulness of the restaurant food environment post-mandatory menu labeling, specifically in the Southern United States. This study aims to assess the healthfulness of fast-food and full-service chain restaurant environments after compliance with mandatory menu labeling. Methods: The healthfulness of 46 representative fast-food and full-service chain restaurants in 16 Georgia counties was examined using the Nutritional Environment Measures in Restaurants (NEMS-R) survey. The scores were compared between full-service and fast-food restaurants using t-tests across several healthfulness measures such as facilitators and barriers to healthful eating. Results: Fast-food restaurants had more barriers to healthy eating than full-service restaurants. Specifically, fast-food restaurants, compared to full-service restaurants were more likely to encourage large portions (60.9% vs. 17.4%, p=0.006) and offer combination meals at a cheaper price than the sum price of individual items (56.5% vs. 21.7%, p=0.033). Conclusions: Findings on the post-menu labeling chain restaurant food environment in our study does not show improvements from the extant evidence on pre menu labeling food environment. Further, NEMS-R scores for both fast-food and full-service restaurants indicated the need for improvements in the healthfulness of chain fast-food and full-service restaurants’ food environments

Student and Faculty Preferences Regarding Instructional Modalities at an HBCU Business School as a Result of Covid-19 – A Change Management Approach and Mindset

The COVID-19 pandemic has had a major impact on the higher education community, especially the Historically Black Colleges and Universities (HBCUs). At a micro-level, the HBCU business schools have felt the effects as well, particularly in critical areas such as instructional modalities and the overall classroom experience. Since COVID-19 has changed the educational game, what do key stakeholder groups now prefer regarding instructional modalities in the HBCU business school? This study will answer this question and more while incorporating a change management approach and mindset for leadership and decision-making

Engaging and empowering students as change agents in science education

Students engaged as partners in pedagogical research can be empowered to become change agents in higher education. Students often bring unique insight, perceptions and ideas that complement faculty expertise regarding teaching practices. In this session, we will explore a partnership model that we have used to engage a team of undergraduate Science students with Science faculty and staff to create novel cancer biology pedagogy. Specifically, the undergraduate student researchers will showcase their strategies in working collaboratively to develop 1) a cancer biology teaching lab that will be implemented into the first-year Biology courses, and 2) a cancer biology workshop for public education with our community partners, Let’s Talk Science and the Windsor Cancer Research Group. In addition to promoting a deeper understanding of cancer biology and science education, we will also demonstrate how this model builds and strengthens student-faculty partnerships in Science and creates new pathways for engagement and networking of students within the community. Equipped with these transformative experiences, students are empowered to take on educational leadership roles and hence become positive change agents of higher education in Science. We will also consider mechanisms for adopting our model of student-faculty partnerships to other disciplines, thus enriching the overall teaching culture

Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen

Many genetically modified mouse strains are now available on a C57BL/6 (H-2b) background, a strain that is relatively resistant to collagen-induced arthritis. To facilitate the molecular understanding of autoimmune arthritis, we characterised the induction of arthritis in C57BL/6 mice and then validated the disease as a relevant pre-clinical model for rheumatoid arthritis

Women\u27s preferences for selective estrogen reuptake modulators: an investigation using the time trade off technique

PurposeSelective Estrogen Receptor Modulators (SERMs) reduce the risk of breast cancer for women at increased risk by 38%. However, uptake is extremely low and the reasons for this are not completely understood. The aims of this study were to utilize time trade-off methods to determine the degree of risk reduction required to make taking SERMs worthwhile to women, and the factors associated with requiring greater risk reduction to take SERMs. MethodsWomen at increased risk of breast cancer (N = 107) were recruited from two familial cancer clinics in Australia. Participants completed a questionnaire either online or in pen and paper format. Hierarchical multiple linear regression analysis was used to analyze the data. ResultsOverall, there was considerable heterogeneity in the degree of risk reduction required to make taking SERMs worthwhile. Women with higher perceived breast cancer risk and those with stronger intentions to undergo (or who had undergone) an oophorectomy required a smaller degree of risk reduction to consider taking SERMs worthwhile. ConclusionWomen at increased familial risk appear motivated to consider SERMs for prevention. A tailored approach to communicating about medical prevention is essential. Health professionals could usefully highlight the absolute (rather than relative) probability of side effects and take into account an individual’s perceived (rather than objective) risk of breast cancer

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

Introduction: Type 4 phosphodiesterases (PDE4) play an important role in immune cells through the hydrolysis of the second messenger, cAMP. Inhibition of PDE4 has previously been shown to suppress immune and inflammatory responses, demonstrating PDE4 to be a valid therapeutic target for immune-mediated pathologies. We assessed the anti-inflammatory effects of a novel PDE4 inhibitor, apremilast, in human synovial cells from rheumatoid arthritis (RA) patients, as well as two murine models of arthritis

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol

Advances in imaging have changed prostate radiotherapy through improved biochemical control from focal boost and improved detection of recurrence. These advances are reviewed in the context of prostate stereotactic body radiation therapy (SBRT) and the ARGOS/CLIMBER trial protocol. ARGOS/CLIMBER will evaluate 1) the safety and feasibility of SBRT with focal boost guided by multiparametric MRI (mpMRI) and 18F-PSMA-1007 PET and 2) imaging and laboratory biomarkers for response to SBRT. To date, response to prostate SBRT is most commonly evaluated using the Phoenix Criteria for biochemical failure. The drawbacks of this approach include lack of lesion identification, a high false-positive rate, and delay in identifying treatment failure. Patients in ARGOS/CLIMBER will receive dynamic 18F-PSMA-1007 PET and mpMRI prior to SBRT for treatment planning and at 6 and 24 months after SBRT to assess response. Imaging findings will be correlated with prostate-specific antigen (PSA) and biopsy results, with the goal of early, non-invasive, and accurate identification of treatment failure